相关实验视频

Updated: May 26, 2025

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

瘤微环境作为淋巴细胞白血病的新型治疗点

Shahrzad Mousavi¹, Soheil Nouri¹, Arezoo Sadeghipour²

¹Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, P.O. Box 14115-111, Tehran, Iran.

Annals of hematology

|February 24, 2025

概括

淋巴性白血病是一个主要的健康问题. 了解瘤微环境 (TME) 以及它与白血病细胞的相互作用是开发新疗法和克服耐药性的关键.

科学领域:

血液学血液学血液学
在瘤学瘤学.
免疫学免疫学免疫学

背景情况:

淋巴性白血病是一个重大的全球健康挑战,导致相当大的发病率和死亡率.
瘤微环境 (TME) 在白血病的发展,进展和治疗耐药性方面发挥着关键作用.
TME包括多样化的细胞,这些细胞创建了一个复杂的信号网络,支持白血病细胞生存和免疫逃避.

研究的目的:

突出瘤微环境 (TME) 在淋巴性白血病中的关键作用.
强调TME对治疗耐药性的贡献,包括多药耐药性 (MDR).
强调需要了解TME-白血病细胞相互作用,以便开发新的向疗法.

主要方法:

关于淋巴性白血病及其瘤微环境的现有文献的综述.
分析TME内部的细胞组件及其信号通路.
检查TME在药物耐药性机制中的作用.

主要成果:

TME是白血病细胞存活,增殖和免疫规避的组成部分.
通过TME介导的交叉声会促进白血病的进展,并使其对传统疗法产生抗性.
多种药物耐药性 (MDR) 在很大程度上受到TME的影响.

结论:

针对TME提供了一个有希望的补充策略,用于指导抗白血病治疗.
对TME组件及其相互作用的全面理解对于设计有效的向疗法至关重要.
开发专注于TME的新疗法可以改善淋巴细胞白血病患者的治疗结果.

关键词:

抗白血病的治疗方法淋巴性白血病是什么淋巴性白血病是什么瘤微环境是一个微环境.

更多相关视频

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...